MARKET

ZLAB

ZLAB

Zai Lab Limited
NASDAQ
32.50
-0.09
-0.28%
After Hours: 30.99 -1.51 -4.65% 19:53 05/22 EDT
OPEN
32.20
PREV CLOSE
32.59
HIGH
32.63
LOW
31.59
VOLUME
618.15K
TURNOVER
--
52 WEEK HIGH
39.77
52 WEEK LOW
16.01
MARKET CAP
3.53B
P/E (TTM)
-13.0491
1D
5D
1M
3M
1Y
5Y
1D
Zai Lab Limited: Banking On Chinese Pharma Growth
Seeking Alpha · 1d ago
NovoCure Limited: Profitability Remains Elusive
Seeking Alpha · 2d ago
Janus Henderson Global Life Sciences Diversified ADR Managed Account Q1 2025 Commentary
Seeking Alpha · 3d ago
Janus Henderson Overseas Fund Q1 2025 Commentary
Seeking Alpha · 4d ago
Zai Lab gets FDA fast track status for lung cancer treatment
Seeking Alpha · 4d ago
Weekly Report: what happened at ZLAB last week (0512-0516)?
Weekly Report · 4d ago
ZAI LAB LTD - TO INITIATE PIVOTAL STUDY FOR ZL-1310 IN 2025
Reuters · 4d ago
Zai Lab’s Growth Amidst Competitive Pressures: Analyst Recommends Hold
TipRanks · 4d ago
More
About ZLAB
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.

Webull offers Zai Lab Ltd - ADR stock information, including NASDAQ: ZLAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLAB stock methods without spending real money on the virtual paper trading platform.